Redmile Biopharma Investments III, L.P.

CIK 1838746 · other company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Redmile Biopharma Investments III, L.P..

Recent SEC filings

FiledFormAccession number
Aug 7, 202640001104659-26-092867
Aug 4, 202630001104659-26-090604
Nov 4, 202140001104659-21-134623
Oct 28, 202130001104659-21-131280
Aug 5, 202130001104659-21-101016
Jan 4, 2021D0001820505-21-000002